Patent · US Active

Compounds, pharmaceutical compositions and methods of use of hydroxamic acid derivatives

US9381196B2 · kind B2 · utility

0Cited by
1References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 19, 2015
Grant dateJul 5, 2016
Priority date
Expiry dateMay 3, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D403/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention encompasses a compound derived from hydroxamic acid that may be used to slow the expansion of cancer cells and thus is effective in the treatment of cancer. Generally, the disclosed compound includes a benzimidazole group coupled to a hydroxyamide of five or more unsubstituted carbon atoms and any pharmaceutically acceptable salts, solvates and chemically protected forms thereof. Also disclosed are pharmacological compositions including the compound and methods of using the compound to slow the expansion of cancer cells as well as methods of using the compound to treat cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.